Salvage Surgical Resection After Linac-based Stereotactic Radiosurgery and Radiotherapy for Newly Diagnosed Brain Metastasis

Purpose: This study aimed to assess the clinical outcomes of salvage surgical resection (SSR) after stereotactic radiosurgery and fractionated stereotactic radiotherapy (SRS/fSRT) for brain metastasis.Methods: Between November 2009 and December 2018, we treated 427 consecutive patients with 919 lesions with SRS/fSRT for newly diagnosed brain metastasis at our hospital. During the follow-up period, we treated 19 consecutive patients who underwent 21 SSRs for recurrence, radiation necrosis (RN), and cyst formation after SRS/fSRT for newly diagnosed brain metastasis. Two patients underwent multiple surgical resections. Brain metastasis originated from the lung (n=15, 78.9%), breast (n=3, 15.7%), and colon (n=1, 5.2%). Results: The median time from initial SRS/fSRT to SSR was 14 months (range: 2–96 months). The median follow-up after SSR was 15 months (range: 2–76 months). The range of tumor volume at initial SRS/SRT was 0.121–21.459 cm3 (median: 2.188 cm3). Histopathological diagnosis after SSR was recurrence, RN and cyst formation in 13 and 6 cases, respectively. The median survival time from SSR and from initial SRS/SRT was 17 months and 74 months, respectively. The cases with recurrence had a significantly shorter survival time than those without recurrence (p=0.0453).Conclusion: The patients treated with SRS/fSRT for brain metastasis need long-term follow-up. SSR is a safe and effective treatment for the recurrence, RN, and cyst formation after SRS/fSRT for brain metastasis.

[1]  I. Nakagawa,et al.  Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection , 2020, Journal of radiation research.

[2]  H. Nakase,et al.  Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for brainstem metastasis. , 2019, World neurosurgery.

[3]  D. Mathieu,et al.  Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases , 2019, Journal of Neuro-Oncology.

[4]  A. Matsumura,et al.  Complications after stereotactic radiosurgery for brain metastases: Incidences, correlating factors, treatments and outcomes. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  S. Miyamoto,et al.  Radiation-induced cystic brain necrosis developing 10 years after linac-based stereotactic radiosurgery for brain metastasis , 2018, Oxford medical case reports.

[6]  S. Lo,et al.  Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases , 2018, Front. Oncol..

[7]  V. Seifert,et al.  Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort , 2018, PloS one.

[8]  Rushikesh S. Joshi,et al.  Cystic Formation After Stereotactic Radiosurgery of Brain Metastasis. , 2018, World neurosurgery.

[9]  R. Colaco,et al.  Radiation Necrosis – A Growing Problem in a Case of Brain Metastases Following Whole Brain Radiotherapy and Stereotactic Radiosurgery , 2018, Cureus.

[10]  D. Kondziolka,et al.  Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery. , 2018, Journal of neurosurgery.

[11]  L. Chambless,et al.  Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases , 2017, Front. Oncol..

[12]  M. McAleer,et al.  Neurosurgical management of brain metastases , 2017, Clinical & Experimental Metastasis.

[13]  A. Laxton,et al.  Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. , 2017, Journal of neurosurgery.

[14]  David A. Larson,et al.  Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases , 2016, Oncotarget.

[15]  K. Sugiyama,et al.  A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis† , 2016, Neuro-oncology practice.

[16]  Yoshiya Yamada,et al.  Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases , 2015, Journal of Neuro-Oncology.

[17]  M. McDermott,et al.  Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. , 2015, Journal of neurosurgery.

[18]  V. Esposito,et al.  Repeated stereotactic radiosurgery for patients with progressive brain metastases , 2015, Journal of Neuro-Oncology.

[19]  D. Shrieve,et al.  Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases. , 2014, Journal of radiosurgery and SBRT.

[20]  T. Schultheiss,et al.  Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery , 2013, Journal of Neuro-Oncology.

[21]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[22]  D. Verellen,et al.  Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc , 2012, Radiation oncology.

[23]  A. Bozzao,et al.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis , 2011, Radiation oncology.

[24]  Y. Shibamoto,et al.  Stereotactic radiotherapy using Novalis for skull base metastases developing with cranial nerve symptoms , 2010, Journal of Neuro-Oncology.

[25]  T. Iijima,et al.  DELAYED CYST FORMATION AFTER GAMMA KNIFE RADIOSURGERY FOR BRAIN METASTASES , 2009, Neurosurgery.

[26]  D. Kondziolka,et al.  The results of resection after stereotactic radiosurgery for brain metastases. , 2009, Journal of neurosurgery.